Skip to content

A randomized, active-controlled, parallel design, prospective multi-center investigator clinical trial to investigate the superiority of medical laser medical device (Ellise) 650nm wavelength over electroacupuncture for short-term pain reduction in patients with nonspecific chronic low back pain

A randomized, active-controlled, parallel design, prospective multi-center investigator clinical trial to investigate the superiority of medical laser medical device (Ellise) 650nm wavelength over electroacupuncture for short-term pain reduction in patients with nonspecific chronic low back pain

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0010475
Enrollment
90
Registered
2025-05-20
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The experimental group will receive 650nm laser therapy using the Ellise medical laser device (manufactured by Wontech Co., Ltd.), while the control group will undergo microcurrent el

Sponsors

Dongshin University Gwangju Oriental Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Participants will be included if they meet all of the following criteria: Participants aged between 19 and 70 years Those with nonspecific chronic low back pain persisting for more than three months and experiencing pain for at least 14 days per month during the three months prior to screening Participants with moderate low back pain, defined as a 100mm Visual Analog Scale (VAS) score between 35 and 74 at screening Those with no difficulty in reading and understanding Korean Participants who voluntarily sign the written informed consent for study participation

Exclusion criteria

Exclusion criteria: Participants will be excluded if they meet any of the following criteria: 1. Radiculopathy or neurological deficits associated with low back pain, including radiating pain to the lower limbs 2. Severe spinal conditions, such as malignant tumors, recent compression fractures, spinal infections, or cauda equina syndrome 3. Serious comorbidities, including cancer, advanced renal, hepatic, cardiovascular, or neurological diseases, as well as diabetic neuropathy 4. History of substance abuse(including alcohol) or psychiatric disorders, including dementia, schizophrenia, epilepsy, or depression requiring treatment within the past six months 5. Other musculoskeletal or systemic conditions that may contribute to low back pain, such as trauma, ankylosing spondylitis, fibromyalgia, rheumatoid arthritis, or gout 6. Contraindications to invasive laser acupuncture, including bleeding disorders, severe skin conditions at the treatment site, implanted metallic devices in the lumbar region, or use of implantable electronic medical devices (e.g., pacemakers) 7. Moderate to severe depression, defined as a Beck Depression Inventory-II (Korean version) score of 23 or higher 8. History of lumbar surgery within the past year or a scheduled procedure 9. Pregnancy or plans to conceive during the study period 10. Concurrent participation in another clinical trial 11. Legal or compensation-related treatment for low back pain 12. Any condition deemed inappropriate for study participation by the principal investigator

Design outcomes

Primary

MeasureTime frame
the difference in Visual Analog Scale score changes

Secondary

MeasureTime frame
the difference in Visual Analog Scale score changes;the difference in the proportion of responders between the experimental and control groups;the change in Oswestry Low Back Disability Questionnaire scores;the change in European Quality of Life Five Dimension Five Level Scale scores

Countries

Korea, Republic of

Contacts

Public ContactJae Hong Kim

Dongshin University

nahonga@hanmail.net+82-62-350-7209

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026